Digital CBT for children with mild depression approved by NIC

NICE recommends digital CBT for children with mild depression

NICE has recommended digital CBT for children and young people with mild depression as a first-line treatment. Digital cognitive behavioural therapy is delivered on mobile phones,...
new recommendation can delay chemotherapy for women with advanced breast cancer

The launch of GP Connect kicks off in Leeds

NHS Digital has taken a major step on the road to ensuring clinicians have access to patients’ GP records right across Leeds with the...
Phase 3 RELAY study of CYRAMZA® met primary endpoint of PFS

Asthma UK: There are more than 10 million asthma attacks each year

Every three seconds someone in the UK could be having a potentially life-threatening asthma attack, according to new research from Asthma UK. The new analysis,...
Sue Bennett has a liver transplant using a procedure to make livers viable for transplant

NICE: Procedure could make more livers viable for transplant

A procedure assessed by NICE has been hailed as an “exciting development” in increasing the number of livers viable for transplant.  A perfusion machine can...
Outdated mental health commissioning contracts are failing services

Outdated mental health commissioning contracts are failing services

A new report reveals that outdated mental health commissioning contracts are failing UK mental health services. The report published by the Janssen Pharmaceutical Companies of...
Seqirus to make entire influenza vaccine production process cell-based

New measles and rubella elimination strategy launched

Public Health England has published a new measles and rubella elimination strategy. It makes recommendations on the steps needed to maintain the UK’s elimination status...
Biodose software system launch

New Biodose software system launch

Dosecare, the medication management company, has announced it has developed new software for Biodose customers. Dosecare, which is owned by Issa Group, a family-owned business...
response to the Long Term Plan

Initial response to the Long Term Plan

Sector response to the Long Term Plan has now been published and it has been welcomed in the main, though cautiously by some. The NHS...
NHS long term plan

NHS long term plan: making the NHS fit for the future

The NHS long term plan, published today, will save almost half a million more lives with practical action on major killer conditions and investment...
New breath test for cancer

Could a new breath test detect multiple cancers earlier?

Researchers have launched a clinical trial to develop a breath test, analysing molecules that could indicate the presence of cancer at an early stage. This...

Latest articles

Study by health experts shows that NHS productivity of the NHS has improved

NHS staff praised as productivity grows

A study by health experts has shown that the productivity of the NHS has improved almost two and a half times faster than the...
Oxford PharmaGenesis awarded second Queen's Award for Enterprise

Oxford PharmaGenesis awarded business accolade

Independent HealthScience communications consultancy Oxford PharmaGenesis has been awarded its second Queen’s Award for Enterprise, the UK’s highest accolade for business success. The consultancy was...
Advance in CAR T therapy eliminates side effects

Advance in CAR T therapy eliminates side effects

A new University of Southern California study has found that an advance in CAR T therapy eliminates side effects and produces remissions without toxicity in...

Popular articles

pain relief patch released by nurofen

Nurofen launches a 24 hour ibuprofen pain relief patch

Nurofen announces the launch of the UK’s only 24 hour clinically proven pain relief patch containing ibuprofen.  Despite body pain being among the most commonly...

Understanding Multiple Sclerosis (MS)

Multiple sclerosis (MS) is a neurological condition affecting the central nervous system. ‘Sclerosis’ means the scarring or hardening of tiny patches of tissue; it...
final recommendation for ILUMETRI ®▼

NICE publishes final recommendation for ILUMETRI ®▼

NICE has published final recommendation for ILUMETRI ®▼ (Tildrakizumab), as a cost-effective option for adults with moderate-to-severe plaque psoriasis. The National Institute for Health and Care...
Electronic prescribing to help hospitals tackle medication errors

Electronic prescribing to help hospitals tackle medication errors

Patientrack's parent company has entered into a reseller agreement with healthcare software provider Better by Marand to help hospitals tackle medication errors. Patientrack provides...
Seqirus to make entire influenza vaccine production process cell-based

Seqirus to make entire influenza vaccine production process cell-based

Influenza vaccine manufacturer Seqirus is to manufacture its cell-based influenza vaccine (FLUCELVAX® TETRA) using cell-based Candidate Vaccine Viruses (CVVs) for all four strains recommended...